Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2023-04-23 Interim / Quarterly Rep…
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 548.9KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement titled 'ACTIVITIES REPORT FOR THE QUARTER – 31st MARCH 2023' and provides a detailed update on the company's operations, financial position, and key activities during the quarter ending March 31, 2023. It includes financial figures such as cash position, revenue, expenditure breakdown, and mentions an attached Appendix 4C (a quarterly cash flow report). The content covers operational highlights, regulatory approvals, sales, financing arrangements, and corporate activities. The document is approximately 15,000 characters long and contains substantive financial data and analysis for the quarter, not merely an announcement or a brief summary. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements or substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. Q3 2023
2023-04-23 English
Resignation of Managing Director and Strategic Review 2 pages 122.8KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 17 April 2023 regarding the resignation of the CEO and Managing Director of Singular Health Group Ltd and the appointment of an interim CEO. It includes details about the strategic review and terms of the interim CEO appointment. There are no financial statements, quarterly or annual results, or detailed financial data. The content focuses on management changes and strategic direction. Therefore, it fits the category of Board/Management Information (MANG). The document length is 4016 characters, which is consistent with a typical announcement rather than a full report.
2023-04-16 English
Final Director's Interest Notice 2 pages 5.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director's Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the securities holdings and interests of a director who has ceased to be a director, including shares, performance rights, and options. This type of document is a formal notification of personal share transactions or holdings by a company director. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a report. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on director interests, confirming this classification with high confidence.
2023-04-16 English
Application for quotation of securities - SHG 6 pages 28.0KB
Capital/Financing Update Classification · 100% confidence The document is an application for quotation of securities on the ASX by Singular Health Group Ltd. It details the number and type of securities to be quoted, issue dates, and references previous announcements such as Appendix 3B related to the placement of securities. The content focuses on the issuance and quotation of new shares as part of a capital raising transaction. There are no financial statements, earnings data, or management discussion. The document is a formal announcement related to capital structure changes and securities issuance, fitting the category of Capital/Financing Update (CAP).
2023-04-10 English
Tranche 1 Placement and Cleansing Statement 2 pages 117.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 11 April 2023 regarding the completion of a tranche 1 placement of new shares by Singular Health Group Ltd. It includes a cleansing notice pursuant to section 708A(5)(e) of the Corporations Act 2001, which is a regulatory compliance statement related to the share issue. The content focuses on the completion of a capital raising event and the legal notice associated with it. The document length is 2275 characters, which is relatively short and is an announcement rather than a detailed report. There are no financial statements or detailed financial analysis present. Therefore, this document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2023-04-10 English
Operational Update, R&D Funding Facility & Strategic Review 4 pages 334.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 6 April 2023 from Singular Health Group Ltd providing an operational update on its subsidiary Singular 3DP, including receipt of certifications, investment in equipment, reseller appointments, sales orders, R&D funding facility, and a strategic review. The content focuses on business operations, funding arrangements, and strategic initiatives rather than detailed financial statements or comprehensive financial performance data. It is not a full annual or interim report, audit report, earnings release, or investor presentation. The document is a corporate update announcement related to capital raising and operational progress, fitting best into the category of Capital/Financing Update (CAP).
2023-04-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.